class 3

Class 3 Medicines Recall: Neon Healthcare Ltd, Suprefact 1 mg/ml solution for injection (Cheplapharm – Canadian Livery), EL(24)A/14

Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.

MDR Number: MDR 191-04/24

Company name: Neon Healthcare Ltd

Product description: Suprefact 1mg/ml solution for injection (Cheplapharm – Canadian Livery)

Details of the affected batch

Batch NumberExpiry DatePack SizeFirst Distributed
3F022A12/20242 multi-dose vials of 5.5ml11 April 2024

Brief description of problem: 

Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure. This is because the named batch of Suprefact 1mg/ml solution for injection is being distributed in packaging intended for the Canadian market by Cheplapharm, instead of the correct UK packaging by Neon Healthcare Ltd for Buserelin 1mg/ml solution for injection.

Advice to Healthcare Professionals:

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Wholesalers are also requested to check stock of Buserelin 1mg/ml solution for injection for any packs that match Suprefact 1mg/ml solution for injection (MAH: Cheplapharm – Canadian Livery) as per the product images in the recall document.

Advice to Patients:

No further action is required by patients as this is a Pharmacy and Wholesaler level recall. Patients who experience adverse reactions or have any questions about the medication, should seek medical attention.  Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

Company contacts for further information:

For medical information or stock control enquiries please contact: Neon Healthcare Ltd via Medinfo@neonhealthcare.com or +44 (0) 1992 926 330

To access the full recall: Class 3 Medicines Recall: Neon Healthcare Ltd, Suprefact 1 mg/ml solution for injection (Cheplapharm – Canadian Livery), EL(24)A/14